Navigation Links
TOX A/B QUIK CHEK

ProductsTOX A/B QUIK CHEK
Company Inverness Medical Innovations
Item TOX A/B QUIK CHEK
Features 
  • Detects both A and B strains
  • Results in 30 minutes
  • Internal control line validates QC result in same reaction window
Description The TOX A/B QUIK CHEK test is a rapid immunoassay to detect Clostridium difficile toxins A and B in fecal specimens. The test uses antibodies specific for toxins A and B of C. difficile and yields >90% sensitivity and >99% specificity compared to tissue culture. Because the test detects both toxin A and toxin B, the risk of false negative results due to A-/B+ strains is greatly reduced.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. NMP22® BladderChek® Kit (24-test kit)
2. NMP22® BladderChek® Kit (1-test kit)
3. NMP22® Test Kit
4. NMP22 BladderChek Test
5. NMP22
6. Vysis UroVysion Bladder Cancer Kit
7. FineTech-Brindley (VOCARE) Bladder System
8. BladderScan BVM 6500
9. Mobile BladderScan® BVI 6400
10. BladderScan® BVI 6300 Bladder Monitor
11. BladderScan® BVI 6100
TAG: TOX QUIK CHEK
The best lens available for gonioscopy and laser trabeculoplasty. One 62 mirror. Tilted anterior surface corrects image and laser beam astigmatism. Unsurpassed resolution. Can be used on most patient
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft.
Lachrymal cannula, straight.
The first easy-to use peroxide system offers proven efficacy that's pure and simple. The convenience of a multi-purpose cleaner/rinse in one bottle. Added power of peroxide in the other bottle.
Medicine Products:
(Date:12/3/2008)...Dec. 3 Breast-Specific Gamma Imagi...pecificity than breast MRI in patients with,incon...in the diagnosis of,breast cancer, according to f...the Radiological Society of North America (RSNA). ... as an adjunctive tool to mammography that can ide...
(Date:12/3/2008)...gests need to change therapeutic guidelines, ,...A pill that contains two blood pressure drugs was ...educing the risk of serious cardiovascular problem...cording to a study that included more than 11,000 ...mark and Finland. , The patients took either a ...
(Date:12/3/2008)..., N.J., Dec. 3 The foll...CEO, New Jersey Hospital Association: , , "...y hospitals will share funding from the state,s $4...lcome news for those facilities, but the more sobe...le hospitals have been turned away. While a worthy...
(Date:12/3/2008)...Dec. 3 Medicsight PLC, an industry...ed Detection (CAD) and medical image analysis soft...tudy that demonstrated CAD significantly increased...lorectal cancers in multi-row detector CT (MDCT) c...hat when both expert and non-expert CTC readers us...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Blood Pressure Pill Combo More Effective Than Diuretics 2Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 2Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 3Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 4Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 5Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 6Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 7
... for Parkinson's disease has given the green signa...educing symptoms for patients,// according to the ...oscience meetings held yesterday and last week the...he 24 patients who received therapy in the two sep...
...ed only by thalassemia intermedia till February 20...ve.// Initially, blood transfusion was not needed...underwent blood transfusion 10 times last year. S...Blood Bank at Maniktala in Kolkata in February. Sh...
...der the aegis of the Health Ministry of Bangladesh...d of five years, is slated to// continue for anoth...n for those under extreme risk, including injected...he extended period will be on safe blood transfusi...
...en we are happy, sad or angry are actually inherit... of University of Haifa, Israel, analysed the faci... from birth along with those of their relatives, r... of BBC. They interviewed the participants, askin...
Other Medicine News:Health News:Gene therapy Beneficial in Parkinson's Disease 2Health News:Gene therapy Beneficial in Parkinson's Disease 3Health News:Thalassemic patient is now HIV positive due to faulty Diagnostic kit… 2
(Date:12/3/2008)...eatment alleviates long-term anemia and organ dama...s , , MEMPHIS, Tenn., Dec. 3 /PRNewswire-U...orrective gene into mouse blood cells, scientists ...viated sickle cell disease pathology. In their stu...showed essentially no difference from normal mice....
(Date:12/3/2008)...if., Dec. 3 Bionovo, Inc...has reviewed the company,s,manufacturing and cont...guidance on how Bionovo can move forward with the ... menopausal hot flashes. , "We have conclud...ing to,address the Agency,s recommendations for f...
(Date:12/2/2008)...ec. 2 IBT Laboratories, a leading ...ratory specializing in immunology and allergy assa...valuate the response of patients whose immune sys...iciency disorder, chemotherapy drugs, or because t... rejection of a transplant. The company launched t...
(Date:12/1/2008)... CHICAGO, Dec. 2 A st...PEM), a new technique for imaging the breast, is n...hormonal status, two factors that limit the effect...ng cancer. Results will be presented today at the ...h America (RSNA). , , "The ability of PEM ...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 2Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 4IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4SEIU Members Renew Call for CNA Labor Leaders to Address Deplorable Tactics Harming Nurses and Patient Care 16904 1SEIU Members Renew Call for CNA Labor Leaders to Address Deplorable Tactics Harming Nurses and Patient Care 16904 2SEIU Members Renew Call for CNA Labor Leaders to Address Deplorable Tactics Harming Nurses and Patient Care 16904 3SEIU Members Renew Call for CNA Labor Leaders to Address Deplorable Tactics Harming Nurses and Patient Care 16904 4Vion Pharmaceuticals Files Plan With Nasdaq 4626 1Vion Pharmaceuticals Files Plan With Nasdaq 4626 2Vion Pharmaceuticals Files Plan With Nasdaq 4626 3FTY720 a novel oral therapy in development for MS shows sustained benefits for the majority of patients after three years of treatment 1809 1FTY720 a novel oral therapy in development for MS shows sustained benefits for the majority of patients after three years of treatment 1809 2FTY720 a novel oral therapy in development for MS shows sustained benefits for the majority of patients after three years of treatment 1809 3FTY720 a novel oral therapy in development for MS shows sustained benefits for the majority of patients after three years of treatment 1809 4FTY720 a novel oral therapy in development for MS shows sustained benefits for the majority of patients after three years of treatment 1809 5FTY720 a novel oral therapy in development for MS shows sustained benefits for the majority of patients after three years of treatment 1809 6Sleep Disorder Linked to Neurodegenerative Conditions 16902 1Sleep Disorder Linked to Neurodegenerative Conditions 16902 2
...INESS WIRE)--May 30, 2007 - CELSION CORPORATION,(A...se I dose,escalation study, using ThermoDox(R), to...h was conducted under a Cooperative Research,and D...National,Cancer Institute (NCI) of the National In...even K. Libutti, Senior Investigator, Head,Tumor ...
...SINESS WIRE)--May 30, 2007 - Rexahn,Pharmaceutical...,dedicated to the discovery, development, and comm... central nervous system disorders,sexual dysfunct...,that Dr. John Marshall, Principal Investigator of...er compound RX-0201 (Archexin),will present resul...
Other Medicine Technology:Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3